Macron to unveil Novo Nordisk pharma investment in France
- Country:
- France
French President Emmanuel Macron will on Thursday inaugurate a "major investment" by Danish pharmaceutical company Novo Nordisk in France, his office said on Wednesday, pitching it as a sign of newly restored French industrial competitiveness.
The investment, for which no detail was provided by Macron's office, will be based in Chartres, west of Paris, where Novo already employs nearly 2,000 people. Novo, known for its hugely popular anti-obesity drug Wegovy, produces insulin in France.
ALSO READ
-
Dora Moutot’s Conviction Sparks UN Expert’s Concern Over Women’s Safety and Free Speech
-
UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks in Court
-
France Plans Housing Hub to Unlock European Funding and Technical Expertise
-
AfDB and France Build €2.4 Billion Partnership for Jobs and Growth
-
The Azcatitlan Codex Returns: A Historical Reunion After 183 Years
Google News